Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population
Ml. Lara-marquez et al., Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population, CLIN EXP AL, 29(1), 1999, pp. 60-71
Background Genes linked to the major histocompatibility complex (MHC), have
been implicated in atopic asthma. Asthma is highly prevalent in the Venezu
elan population (estimated at 20%) and genetic markers are needed to identi
fy populations at risk and plan intervention strategies.
Objective To study the influence of the MHC class I and class Il genes in t
he susceptibility to atopic asthma.
Methods MHC-class I HLA-A, -C, -B and MHC-class II HLA-DR, -DQ, -DP gene ha
plotype frequencies were determined in 135 Venezuelan mestizos, 71 belong t
o 20 atopic asthmatic families and 64 unrelated controls. The index cases w
ere 20 atopic asthmatics with positive skin-prick tests and specific serum
immunoglobulin E (IgE) for Dermatophagoides pteronyssinus (Der p) and Derma
tophagoides farinae (Der f). To ascertain the genes associated with suscept
ibility to atopy and/or asthma, two control groups were studied, 41 non-ato
pic subjects with skin-prick negative test, and undetectable levels of spec
ific IgE and 23 non-asthmatic atopic subjects with detectable specific IgE
to Der p and Der f. A linkage analysis was performed in those families with
two or more atopic siblings (with or without asthma).
Results MHC-class I genes analysis showed that HLA-Cw7 was absent in the as
thmatic patients studied, whereas the frequency of this allele was 14.3% in
non-atopic controls (P = 0.017, PC = 0.19) and 20.8% in the atopic control
s (P = 0.0066, PC = 0.07). MHC-class II gene analysis showed a significant
increase of the HLA-DRB1*11 in the asthmatic patients compared with non-ato
pic controls (allele frequencies of 25.6 vs 4.4% P = 0.0017, PC= 0.02). The
re were no significant differences among asthmatic and atopic controls in t
he frequency of HLA-DRB1*11 (25.6 vs 17.4%). In contrast, the HLA-DRB1*1101
+ haplotypes were significantly higher in asthmatics compared with atopic a
nd non-atopic controls (19.6% vs 2.2% vs 2.3%, PC < 0.05). The HLA-DRB1*110
1, DQA1*0501, DQB1*0301 haplotype was found significantly increased in the
patients vs non-atopic controls (15.4 vs 1.1%, PC < 0.01). The serum levels
of specific IgE were detectable in both atopic asthmatics and atopic contr
ols; however, it was higher in atopic asthmatics vs atopic controls Der p (
median, 58.7 vs 2.7 kU/L, P < 0.001) and Der f (median, 46.9 vs 2.7 kU/L, P
< 0.001). No linkage between MHC genes and mite-atopy could be documented
on informative families with two or more atopic siblings.
Conclusions We have identified an association between the haplotype HLA-DRB
1*1101, DQA1*0501, DQB1*0301 and atopic asthma that confers susceptibility
to develop mite-sensitive asthma to atopics (relative risk, RR 8.2), and to
non-atopic controls (RR = 15.8) that carry this haplotype. Conversely, the
allele HLA-Cw7 was absent in the asthmatics studied and had higher frequen
cies in the atopic (RR = 0.05) and non-atopic (RR = 0.08) controls. Thus, i
t may have a protective role for developing atopic asthma in the population
studied.